Orthopedic surgeon to know: Dr. Tad Gerlinger of Rush University Medical Center

Tad Gerlinger, MD, is a board-certified orthopedic surgeon practicing at Rush University Medical Center in Chicago. He specializes in hip replacement, knee replacement, knee surgery and minimally invasive knee replacement among many others.

Advertisement

He has authored and contributed many scientific publications. His research interests include implant design and survival, arthroplasty in young and activity patients as well as total hip and knee replacement clinical outcomes.

 

Dr. Gerlinger attended medical school at F. Edward Hebert School of Medicine — Uniformed Services University of the Health Sciences in Maryland. He completed orthopedic surgery residencies at the Madigan Army Medical Center in Tacoma, Wash., and the University of Washington Medical Center in Seattle. Dr. Gerlinger completed a fellowship in orthopedic surgery from Rush University Medical Center.

 

More on orthopedics:
Dr. Steven Meier offers pro bono prolotherapy treatments to LA community — 5 notes
Orthopedic surgeon to know: Dr. Archie Heddings of the University of Kansas Hospital
Dr. Eric Henderson receives VA career development award: 4 notes

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in Orthopedic

Advertisement

Comments are closed.